Economic Aspects of Access to Medicines after 2005: Product Patent Protection and Emerging Firm Strategies in the Indian Pharmaceutical Industry (original) (raw)
2010
An analysis of the innovation in the Indian pharmaceutical industry is done. This section traces the origins, the strengths and weaknesses of the innovation system in the pharmaceutical sector in India, and its industrial structure and activities, in order to establish the importance of the Indian industry for access to medicines in the developing world today. This section also arrives upon a categorization of firms in the Indian industry, based on empirical data, which is used in the rest of the study to draw conclusions on various issues. A discussio of the main changes that are forcing a transition in the industry today, of which the introduction of product patent protection is the main one.
Related papers
The Indian Pharmaceutical Patent Regime: Protection of Innovation Vis-À-Vis Access to Medicines
The Indian pharmaceutical industry is a prime example of an industry that is being forced to revisit its long-term strategies and business models as India opens its markets to global trade. Factors such as protection of intellectual property are increasing in significance due to the growing recognition of the need to ensure protection of valuable investments in research and development (R&D). Efforts are being made to curb problems of weak enforceability of existing intellectual property legislations, and the Indian government is moving towards establishing a patent regime that is conducive to technological advances and is in keeping with its global commitments including the Trade-Related Aspects of Intellectual Property Rights (TRIPS). Patents on medicines have been one of the most hotly-debated topics since the adoption of the TRIPS Agreement because patents grant exclusivity for the duration of the patent term and result in patent holders having control over the production, suppl...
Technological Forecasting & Social Change, 2012
Recent patent-law changes in India's pharmaceutical industry provide opportunities to study changes of institutional and regulatory environments on innovation and social welfare in low-income markets. From 1972 to 2004 under its process-patent regime, India's pharmaceutical industry grew to become the world's fourth largest. Indian companies were becoming globally competitive in generics and clinical testing, and moving into product R&D. Researchers have debated the effects of India's new product-patent laws' effects on these trends. The authors cover the domestic characteristics and global competitiveness of India's pharmaceutical industry. They contrast data (from 2001 to 2004) on patents in India's process-patent regime with preliminary data (from 2005 to 2008) on patents in the country's new product-patent regime. They argue that Indian pharmaceutical companies have changed their decision-making in response to changed patent laws by moving from process to product research. However, the preliminary results indicate that these changes may have hurt domestic innovation. They conclude with strategic implications for the Indian pharmaceutical industry and highlight the need for research and public policy to establish optimal social returns from product-patent regimes.
The Indian Pharmaceutical Industry : The Empirical Study
This paper aims at accessing the growth of Indian pharmaceutical industry, after the process of economic liberation in India and more particularly after the change in patent laws in India. In the process patent regime era Indian pharmaceutical companies were able to supply the cheapest generic drugs in the world but the advantage of process patent laws is not available to the industry after 1'st January 2005. The pharmaceutical industry has to evolve to confront the current situation and if possible new avenues for growth have to be explored. The objective of present study is to predict the prospects of Indian pharmaceutical industry.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.